Joe Rogan Experience #2454 - Robert Malone, MD
TL;DR
Dr. Robert Malone returns to discuss his early warnings about mRNA vaccine safety, his personal adverse reactions to Moderna after trusting assurances that distribution issues were solved, and claims that the FDA obstructed Department of Defense-funded research into repurposed drugs like ivermectin.
🧬 mRNA Technology Origins and Risks 3 insights
Early animal studies showed severe inflammation
Malone's original research demonstrated aggressive white cell infiltrates and systemic distribution in mice and monkeys, leading him to abandon the technology as clinically unsafe due to unacceptable inflammatory responses.
Lipid nanoparticles promised localization solutions
University of British Columbia scientist Peter Cullis claimed that polyethylene glycol (PEG) modifications would restrict the vaccine to draining lymph nodes, convincing Malone that the distribution problems had been solved.
Core safety issues persisted despite claims
Malone experienced adverse neurological events including finger tingling immediately after his second dose, suggesting the historical inflammation and systemic distribution problems were not fully resolved.
đź’‰ Personal Medical Decisions and Long COVID 2 insights
Vaccination ended year-long COVID symptoms
After contracting COVID-19 in February 2020 in Boston, Malone suffered months of stamina loss and pulmonary dysfunction that persisted until he took the Moderna vaccine in 2021 primarily to restore international travel capabilities.
Medical community criticized his choice
His own cardiologist immediately questioned why someone with nine mRNA patents and deep knowledge of the technology's historical failures would take the vaccine, reflecting internal skepticism among specialists.
đźš« Suppression of Repurposed Drug Research 3 insights
DoD allocated significant funding for alternatives
Malone secured over $100 million in Department of Defense contracts to conduct adaptive clinical trials on repurposed drug combinations including famotidine, celecoxib, and ivermectin.
FDA obstructed ivermectin trials
The agency repeatedly rejected clinical trial applications for the ivermectin protocol, demanding unnecessary cell culture tests that ultimately forced the DoD to remove the component despite established safety profiles.
Self-treatment validated computational approaches
While severely ill with COVID-19, Malone used computational docking to identify famotidine and experienced immediate symptom relief, demonstrating the viability of rapid repurposed drug identification during outbreaks.
Bottom Line
Verify institutional assurances about novel medical technologies against historical safety data, particularly when regulatory agencies simultaneously obstruct research into inexpensive, established alternatives.
More from Joe Rogan Experience
View all
Joe Rogan Experience #2518 - Tim Dillon
Joe Rogan and Tim Dillon contrast American excess with European moderation, diagnose Los Angeles' economic collapse driven by anti-business policies, and warn about alarming free speech restrictions in the UK where citizens face arrest for social media activity.
Joe Rogan Experience #2517 - Taylor Sheridan
Taylor Sheridan joins Joe Rogan to explore how neurodivergence fuels creative hyperfocus, the genetic intricacies of horse breeding, and how institutional corruption—from the nonprofit industrial complex to foreign-funded ideological warfare—threatens societal stability through perverse incentives and regulatory overreach.
JRE MMA Show #181 with Justin Gaethje & Trevor Wittman
Justin Gaethje reflects on capturing the UFC title against Ilia Topuria after 19 years of grinding, discussing the mental fortitude required to overcome adversity without expectations, while coach Trevor Wittman reveals the father-like guidance and honest communication that forged their championship bond.
Joe Rogan Experience #2516 - Rowan Jacobsen
Author Rowan Jacobsen reveals that moderate sun exposure extends lifespan and triggers beneficial biochemical reactions like opiate release and improved cognition, despite increasing skin cancer risk. The key distinction is that melanoma correlates with burning episodes rather than gentle daily exposure, and individual skin type—from dark skin that blocks 97% of UV to fair skin with genetic mutations—dramatically alters risk profiles.